1.23  -0.078 (-5.96%)		10-24 15:02
Open: 1.31 High: 1.31 Volume: 123,955		Pre. Close: 1.308 Low: 1.22 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	2.55	1-year :	3.32
Resists	First :	2.18	Second :	2.84
Pivot price	1.6
Supports	First :	1.12	Second :	0.93
MAs	MA(5) :	1.24	MA(20) :	1.66
	MA(100) :	3.2	MA(250) :	20.73
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	7.3	D(3) :	5.4
RSI	RSI(14): 33.6
52-week	High :	144.35	Low :	0.1

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ NIVF ] has closed above bottom band by 19.9%. Bollinger Bands are 59.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 130 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.31 - 1.32	1.32 - 1.33
Low:	1.14 - 1.15	1.15 - 1.16
Close:	1.29 - 1.31	1.31 - 1.32

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.

Mon, 20 Oct 2025
NewGenIvf signs deal to tokenize art collection worth up to $200 million - Investing.com

Mon, 20 Oct 2025
NewGenIVF Group Limited Engages in Art Tokenization Partnership with World Chinese Museum Co., Ltd. - Quiver Quantitative

Mon, 20 Oct 2025
NewGenIvf Group Limited Announces Strategic Entry into Art Tokenization Market with $2 Million Private Collection Deal, Expandable to $200 Million - MarketScreener

Fri, 17 Oct 2025
What's Going On With NewGenIvf Shares Friday? - Benzinga

Fri, 10 Oct 2025
NewGenIVF Group Limited Receives Equity Research Coverage from Zacks Small-Cap Research - Quiver Quantitative

Mon, 06 Oct 2025
NewGenIVF Group Limited Valuation Report Confirms Acquisition of IP at US$17.9 Million, Enhancing NAV per Share by US$8.9 - Quiver Quantitative

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Plans
Shares Out	2 (M)
Shares Float	2 (M)
Held by Insiders	1 (%)
Held by Institutions	0.3 (%)
Shares Short	65 (K)
Shares Short P.Month	50 (K)

EPS	28.68
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	4.3
Profit Margin	12.5 %
Operating Margin	-160.5 %
Return on Assets (ttm)	-31.4 %
Return on Equity (ttm)	307 %
Qtrly Rev. Growth	-24.8 %
Gross Profit (p.s.)	0.69
Sales Per Share	2.21
EBITDA (p.s.)	-1.91
Qtrly Earnings Growth	0 %
Operating Cash Flow	-13 (M)
Levered Free Cash Flow	-15 (M)

PE Ratio	0.04
PEG Ratio	0
Price to Book value	0.28
Price to Sales	0.55
Price to Cash Flow	-0.2

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.